Novo Nordisk (NYSE: NVO) Stock Price Prediction and Forecast 2025-2030 (May 2025)24/7 Wall Street • 05/21/25
Novo Nordisk is betting on a CEO shakeup to regain its weight loss drug edge over Eli LillyCNBC • 05/19/25
Septerna: Deal With Novo Nordisk Is A Game Changer While It Still Trades Well Below Net CashSeeking Alpha • 05/16/25
Ozempic maker Novo Nordisk ousts CEO amid plunging share price as rival Eli Lilly gains market shareNew York Post • 05/16/25
Novo Nordisk Sheds 4% After Ousting CEO As Eli Lilly Rivalry Slams Stock PriceInvestors Business Daily • 05/16/25
Novo Nordisk Stock Gains 14% in a Month: What Should Investors Do?Zacks Investment Research • 05/16/25
Novo Nordisk CEO to step down amid pressure from obesity drug competitionProactive Investors • 05/16/25